Skip to main navigation Skip to search Skip to main content

A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate the Efficacy, Safety, and Tolerability of IXMYELOCEL-T in Subjects with Critical Limb Ischemia and No Options for Revascularization

Stony Brook University

Project: Research

Project Details

StatusFinished
Effective start/end date04/24/12 → 01/11/14

Funding

  • Aastrom Biosciences Incorporated: $7,000.00